$PACB News
Last published 1w ago
- 1w agoPACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 5.02 Item 9.01
- 1w agoPACBPacBio Announces Third Quarter 2026 Financial ResultsGlobeNewswireMENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter ended September 30, 2026. Recent Business Highlights Delivered total revenue of $40.6
- 2w agoPACBPacBio to Participate in Upcoming Investor ConferencesGlobeNewswireMENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the
- 3w agoPACBPacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AIGlobeNewswireMENLO PARK, Calif. and DALLAS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world’s most advanced sequencing technologies, and Verily Health Inc., a healthcare data intelligence company,
- 4w agoPACBPacBio to Report Third Quarter 2026 Financial Results on November 4, 2026GlobeNewswireMENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2026 financial results on Wednesday, November 4,
- 1mo agoPACBPacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA TherapeuticsGlobeNewswireMENLO PARK, Calif. and PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world’s most advanced sequencing technologies, and TychoBio, an AI drug discovery company, today announced a
- 1mo agoPACBMorgan Stanley 24th Annual Global Healthcare Conference - PACIFIC BIOSCIENCES OF CALIFORNIA INCEarnings Call TranscriptsAll right. Thank you very much for joining us today. My name is Mike Piddle. I lead Morgan Stanley's U.S. Life Science Tools and Diagnostics coverage in the Healthcare Investment Banking Group. It's my pleasure to introd
- 1mo agoPACBMorgan Stanley 24th Annual Global Healthcare Conference - PACIFIC BIOSCIENCES OF CALIFORNIA INCEarnings Call TranscriptsAll right. Thank you very much for joining us today. My name is Mike Piddle. I lead Morgan Stanley's U.S. Life Science Tools and Diagnostics coverage in the Healthcare Investment Banking Group. It's my pleasure to introd
- 1mo agoPACBMorgan Stanley 24th Annual Global Healthcare Conference - PACIFIC BIOSCIENCES OF CALIFORNIA INCEarnings Call TranscriptsAll right. Thank you very much for joining us today. My name is Mike Piddle. I lead Morgan Stanley's U.S. Life Science Tools and Diagnostics coverage in the Healthcare Investment Banking Group. It's my pleasure to introd
- 2mo agoPACBPacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare ConferenceGlobeNewswireMENLO PARK, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside
- 3mo agoPACBCG 46TH ANNUAL GROWTH CONFERENCE - PACIFIC BIOSCIENCES OF CALIFORNIA INCEarnings Call TranscriptsHi, welcome to the Canaccord Genuity Growth Conference. I'm Kyle Mixon. I cover Lifestyle and Supplemental Diagnostics for Canaccord. Please welcome me to a Fireside Chat with PacBio. PacBIO offers some of the leading pr
- 3mo agoPACBCG 46TH ANNUAL GROWTH CONFERENCE - PACIFIC BIOSCIENCES OF CALIFORNIA INCEarnings Call TranscriptsHi, welcome to the Canaccord Genuity Growth Conference. I'm Kyle Mixon. I cover Lifestyle and Supplemental Diagnostics for Canaccord. Please welcome me to a Fireside Chat with PacBio. PacBIO offers some of the leading pr
- 3mo agoPACBPacBio Appoints Mark Van Oene as President and Chief Executive OfficerGlobeNewswireMENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) ("PacBio"), a leading developer of high-quality, highly accurate sequencing solutions, today
- 3mo agoPACBPacBio Announces Second Quarter 2026 Financial ResultsGlobeNewswireMENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter ended June 30, 2026. Recent Business Highlights Total revenue of $39.0 million was driven
- 3mo agoPACBPacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega systemGlobeNewswireMENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry and an
- 3mo agoPACBPacBio to Participate in the Canaccord Genuity 46th Annual Growth ConferenceGlobeNewswireMENLO PARK, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside
- 3mo agoPACBPacBio to Report Second Quarter 2026 Financial Results on August 5, 2026GlobeNewswireMENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2026 financial results on Wednesday, August 5,
- 5mo agoPACBPacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced SequencingGlobeNewswireMENLO PARK, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced that SPRQ-Nx sequencing chemistry and new multi-use SMRT Cells
- 5mo agoPACBPacBio to Participate in the Jefferies Global Healthcare ConferenceGlobeNewswireMENLO PARK, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat
- 5mo agoPACBBlank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision OncologyBusiness WireCollaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomes Blank Bio, an applied AI research lab training foundation models for RNA, today
- 6mo agoPACBHiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy LossGlobeNewswireMENLO PARK, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced the publication of a preprint describing the first major study
- 6mo agoPACBPacBio Announces First Quarter 2026 Financial ResultsGlobeNewswireMENLO PARK, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter ended March 31, 2026. Recent Business Highlights Selected by Basecamp Research to power its
- 6mo agoPACBPacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read SequencingGlobeNewswireMENLO PARK, Calif. & BERLIN, April 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a premier developer of sequencing solutions, and Lucid Genomics GmbH, a provider of cutting-edge bioinformatics software for
- 6mo agoPACBPacBio to Report First Quarter 2026 Financial Results on May 7, 2026GlobeNewswireMENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026,
- 7mo agoPACBPacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor SamplesGlobeNewswireMENLO PARK, Calif. and WOBURN, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in
- 8mo agoPACBRXRXPacBio Announces the Appointment of Chris Gibson to the Board of DirectorsGlobeNewswireMENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to
- 8mo agoPACBPacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease ResearchGlobeNewswireMENLO PARK, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced a collaboration with DNAstack to power the world's first
- 8mo agoPACBPacBio to Participate in the TD Cowen 46th Annual Health Care ConferenceGlobeNewswireMENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat
- 9mo agoPACBFourth Quarter 2025 Earnings Conference Call - PACIFIC BIOSCIENCES OF CALIFORNIA INCEarnings Call TranscriptsGood day, and welcome to PACBio's fourth quarter and full year 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing th
- 9mo agoPACBPacBio Announces Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswireMENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results: Q4 2025Q4
- 9mo agoPACBPacBio Joins iHope Initiative as First Long-Read Genomic Sequencing PartnerGlobeNewswireMENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare disease
- 9mo agoPACBPacBio Completes Sale of Short-Read Sequencing AssetsGlobeNewswireMENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual
- 9mo agoPACBPacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026GlobeNewswireMENLO PARK, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Thursday,
- 10mo agoPACBPacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic DiseasesGlobeNewswireMENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration with the n-Lorem
- 10mo agoPACBPacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)GlobeNewswireMENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced that a UW Medicine and Seattle Children's research effort
- 10mo agoPACBPacBio Announces Preliminary Fourth Quarter and Full Year 2025 RevenueGlobeNewswireMENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the fourth quarter of
- 10mo agoPACBPacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT CellGlobeNewswireMENLO PARK, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced CiFi, a new community-developed method that enables
- 10mo agoPACBPacBio to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireMENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th
- 11mo agoPACBPacBio to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswireMENLO PARK, Calif., Nov. 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat
- 12mo agoPACBPacBio to Present at Upcoming Investor ConferencesGlobeNewswireMENLO PARK, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the
- 1y agoPACBThird Quarter 2025 Earnings Conference Call - PACIFIC BIOSCIENCES OF CALIFORNIA INCEarnings Call TranscriptsGood day and welcome to the PACBio third quarter 2025 earnings conference call. All participants will be in listen-only mode. Should you need any assistance please signal a conference specialist by pressing the star key
- 1y agoPACBPacBio Announces Third Quarter 2025 Financial ResultsGlobeNewswireMENLO PARK, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter ended September 30, 2025. Third quarter results: Q3 2025Q3 2024Revenue$38.4 million$40.0
- 1y agoPACBHiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi GenomesGlobeNewswireMENLO PARK, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced the publication of a new preprint from the HiFi Solves
- 1y agoPACBPacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in ChinaGlobeNewswireMENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced that, through its long-standing partnership with Berry
- 1y agoPACBPacBio to Report Third Quarter 2025 Financial Results on November 5, 2025GlobeNewswireMENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5,
- 1y agoPACBPacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic CapabilitiesGlobeNewswireMENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega platforms designed to
- 1y agoPACBPacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome ProjectGlobeNewswireMENLO PARK, Calif. and SEOUL, South Korea, Oct. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its HiFi sequencing
- 1y agoPACBLong Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional LongevityGlobeNewswireMENLO PARK, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, highly accurate long-read sequencing solutions, today announced that the National Institute on Aging's
- 1y agoPACBPacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More LabsGlobeNewswireMENLO PARK, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced an expanded partnership with seqWell, a global
- 1y agoPACBPacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging GenesGlobeNewswireMENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the high-throughput carrier